序号 |
标题 |
次数 |
作者 |
发布时间 |
83161 |
NOTA-p-NCSA-Me-Tetrazine-amine |
100 |
zyl |
2024-11-29 |
83162 |
C13-DBCO的用途与应用 |
135 |
wyh |
2024-11-29 |
83163 |
2C-p-NETA-NCS-Fmoc-D-赖氨酸 |
96 |
zyl |
2024-11-29 |
83164 |
DOTA-Glu-[cyclo (Arg-Gly-Asp-d-Phe-Lys)] |
129 |
wyh |
2024-11-29 |
83165 |
金刚烷修饰超支化聚丙烯酸酯 HBPA-AD |
147 |
h |
2024-11-29 |
83166 |
NOTA-CONH-PEG23-NH-CO-CH2-CH2-Mal |
115 |
zyl |
2024-11-29 |
83167 |
金刚烷修饰六面体倍半硅氧烷 AD-POSS |
196 |
h |
2024-11-29 |
83168 |
大环配体化合物Gd-DOTA-RGD ,NOTA/NOTA-PEG-多肽 |
89 |
wyh |
2024-11-29 |
83169 |
金刚烷修饰纳米抗体7D12 AD-7D12 |
162 |
h |
2024-11-29 |
83170 |
TOC奥曲肽修饰 ; 68Ga-DOTA-Ingr |
142 |
wyh |
2024-11-29 |
83171 |
AD-PEG-FITC 金刚烷聚已内酯异硫氰酸荧光素 |
124 |
h |
2024-11-29 |
83172 |
偶氮苯修饰半乳糖化聚乙二醇 Az-PEG-Gal |
192 |
h |
2024-11-29 |
83173 |
DOTA/DFO-PSMA-617 , DOTA偶联达尔-PSMA-617复合体 |
170 |
kx |
2024-11-29 |
83174 |
金刚烷修饰的1,2-二氧环丁烷 |
190 |
h |
2024-11-29 |
83175 |
DOTA-Ala-Ala-Tyr-COOH的结构组成 |
125 |
wyh |
2024-11-29 |
83176 |
cyclo(RGDFK(DOTA))的性质与功能 |
159 |
wyh |
2024-11-29 |
83177 |
DOTA-SiMPs ,介孔硅纳米结构(SiMPs)共轭四氮杂环十二烷四乙酸(DOTA) |
155 |
kx |
2024-11-29 |
83178 |
FITC标记TAT穿膜肽 ;Gd-DTPA-ACPP |
120 |
wyh |
2024-11-29 |
83179 |
DOTA-Octreotide ,DOTA-奥曲肽 |
97 |
wyh |
2024-11-29 |
83180 |
单克隆抗体B72.3偶联DOTA ,DOTA-B72.3 |
123 |
kx |
2024-11-29 |
83181 |
螯合剂多肽cyclo(RGDFK(DOTA)) ,DOTA-c(RGDfK) |
109 |
wyh |
2024-11-29 |
83182 |
NOTA-(COOt-Bu)2 cas:1161415-28-6 |
103 |
zyl |
2024-11-29 |
83183 |
DOTA-JR10多肽的功能特点 |
152 |
wyh |
2024-11-29 |
83184 |
Biotin-Gd-DOTA ;生物素修饰的钆 |
85 |
wyh |
2024-11-29 |
83185 |
DOTA-CC9 ,细胞膜的环肽CC9偶联DOTA |
204 |
kx |
2024-11-29 |
83186 |
1,4,7,10-四氮杂环十二烷-N.N ',N ",N " '-四乙酸(H4DOTA) |
297 |
kx |
2024-11-29 |
83187 |
NOTA-bis-COOH-Me-Tetrazine 大环配体NOTA-三羧酸-甲基四嗪 |
87 |
zyl |
2024-11-29 |
83188 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[(diphosphonomethyl)amino]-2-oxoethyl]- 定制 |
108 |
zcy |
2024-11-29 |
83189 |
DOTA-pNO2Phe-c[DCys-Tyr-DTrp-Lys-Thr-Cys]-DTyr-NH2 |
133 |
kx |
2024-11-29 |
83190 |
MeTz-PEG7-NOTA 甲基四嗪-聚乙二醇-大环化合物 Me-Tetrazine-PEG7-NOTA |
77 |
zyl |
2024-11-29 |
83191 |
DOTAGA-四叔丁酯,306776-79-4,DOTAGA-(COOt-Bu)4 |
171 |
zcy |
2024-11-29 |
83192 |
金刚烷改性氰酸酯树脂 AD-CE |
188 |
h |
2024-11-29 |
83193 |
DOTA-Tyr-Lys-DOTA ;DOTA-酪氨酸-赖氨酸-DOTA |
75 |
wyh |
2024-11-29 |
83194 |
HA-DOTA tate , DOTA-3-碘-Tyr 3-奥曲肽 , HA-DOTATATE |
104 |
kx |
2024-11-29 |
83195 |
NOTA-E(cRGDfK)2 , NOTA修饰多肽 |
110 |
wyh |
2024-11-29 |
83196 |
叠氮-NOTA cas:2125661-92-7 NOTA-Azide/N3 |
109 |
zyl |
2024-11-29 |
83197 |
金刚烷改性壳聚糖 AD-CS |
150 |
h |
2024-11-29 |
83198 |
DOTA-c(RGDfK) , 螯合物前体多肽 |
144 |
wyh |
2024-11-29 |
83199 |
DOTA-Lys-PEG(4)[D-Phe(6) |
95 |
kx |
2024-11-29 |
83200 |
葫芦[7]脲包裹盐酸金刚烷胺 CB[7]-AD |
126 |
h |
2024-11-29 |
83201 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, 2,2,2-trifluoroacetate (1:) 定制 |
90 |
zcy |
2024-11-29 |
83202 |
N-金刚烷基-N-芳杂基二酰肼类化合物 |
185 |
h |
2024-11-29 |
83203 |
DOTA-奥曲肽 ,DOTA-Octreotide |
115 |
wyh |
2024-11-29 |
83204 |
CAS:147597-66-8 p-SCN-Bn-NOTA |
90 |
zyl |
2024-11-29 |
83205 |
金刚烷衍生物 |
174 |
h |
2024-11-29 |